Translate

Blog 103 Thursday 12th April 2012

All went well yesterday with the removal of the Porta Cath albeit quite painful. As I was in as a day case surgery, the intention is to get the patient out as soon as possible. In less than two minutes my right side chest was shaved, spray frozen, daubed with iodine, and injected with anaesthetic, I was covered almost like a tent and the incision began. within fifteen minutes it was finished and sewn up. With the surgeon's wishes of not wanting to see me again (Meant in the best possible way) I was on my way home. When the anaesthetic wore off , Wow................... trying to sleep was a pain !!!!

Today I was so pleased to read the following article in our local paper for those that have suffered this particular cancer .......................................

NEW WAY TO PREDICT CANCER RETURNING           

Researchers have developed a new breast cancer test “that predicts whether or not their breast cancer will return after surgery”, The Daily Telegraph has today reported. The newspaper says the test may mean that thousands of women with a low risk of recurrence could be spared unnecessary chemotherapy.
The story is based on new research that compared an existing method for predicting cancer recurrence, the Oncotype DX recurrence score (RS), and an adapted version that also took other clinical data into account. To test this new method, called the “recurrence score-pathology-clinical assessment” (RSPC), researchers examined long-term study data on 1,444 women with early-stage, hormone-sensitive cancer that had not spread beyond the breast.
The researchers found that under the RSPC model, more patients were classified as being at low risk for disease recurrence compared to the original test. It did not, however, improve the ability to predict which patients would benefit from receiving chemotherapy. As such, the test should be considered “still in development” and not yet ready for use in practice. Its accuracy and ability to guide treatment choices will now need testing prospectively by applying the model to women with breast cancer before treatment and waiting to see if its results later prove to be accurate.

Read the full article HERE 

No comments: